Research and Markets: Tuberculosis Pipeline Highlights - 2014 Update
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/hvk4z2/tuberculosis) has announced the addition of the "Tuberculosis Pipeline Highlights - 2014 Update" report to their offering.
The latest report Tuberculosis Pipeline Highlights - 2014 Update, provides most up-to-date information on key pipeline molecules in the global Tuberculosis market. It covers emerging therapies for Tuberculosis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Clinical Trial Stages:
The report provides Tuberculosis pipeline molecules by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.
Drug Mechanism Classes:
The report provides Tuberculosis pipeline molecules by their dominant mechanism of action. This helps executives categorize molecules based on their drug class and also assess the strengths and weaknesses of compounds.
The report provides Tuberculosis pipeline molecules by the Originator Company.
Short-term Launch Highlights:
Find out which Tuberculosis pipeline products will be launched in the US and Ex-US till 2017.
Key Topics Covered:
1. Tuberculosis Pipeline by Stages
2. Tuberculosis Pipeline by Drug Class
3. Tuberculosis Pipeline by Company
4. Tuberculosis Phase 3 Clinical Trial Insights
5. Tuberculosis Phase 2 Clinical Trial Insights
6. Tuberculosis Phase 1 Clinical Trial Insights
7. Tuberculosis Preclinical Research Insights
8. Tuberculosis Discovery Stage Insights
10. Research Methodology
For more information visit http://www.researchandmarkets.com/research/hvk4z2/tuberculosis.